Benitec Biopharma Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2019 to 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Benitec Biopharma Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2019 to 2024.
  • Benitec Biopharma Inc. Net Income (Loss) Attributable to Parent for the quarter ending December 31, 2024 was -$7.36M, a 8.22% decline year-over-year.
  • Benitec Biopharma Inc. Net Income (Loss) Attributable to Parent for the twelve months ending December 31, 2024 was -$21.4M, a 1.81% increase year-over-year.
  • Benitec Biopharma Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$21.8M, a 11.2% decline from 2023.
  • Benitec Biopharma Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$19.6M, a 7.44% decline from 2022.
  • Benitec Biopharma Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$18.2M, a 31.2% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.